Subscribe to RSS - BioScrip

BioScrip

BioScrip revenues are down, but core product mix is up

 - 
08/11/2017

DENVER – BioScrip’s net revenues decreased 6.2% in the second quarter of 2017, but CEO Dan Greenleaf said in an earnings call the company was hitting targets.

BioScrip’s losses rack up in Q2

 - 
08/08/2017

DENVER – BioScrip reported net revenues of $218.1 million for the second quarter of 2017 compared to $232.4 million for the same period a year ago. Net loss was $29.2 million vs. $8.2 million.

In brief: Judge deals setback to Arriva Medical, BioScrip reports earnings

 - 
05/05/2017

CORAL SPRINGS, Fla. – Arriva Medical on April 25 lost an appeal seeking to reinstate its Medicare billing privileges, according to news reports.

BioScrip earnings ‘in line’ with expectations

 - 
05/05/2017

DENVER – BioScrip reported net revenues of $217.8 million for the first quarter of 2017, reflecting a core revenue mix of 72% compared to 60% during the same quarter in 2016. Net loss was $19 million and adjusted EBITD was 5.2 million.

'Clear mission' says Greenleaf

 - 
03/22/2017

With one full financial quarter under his belt, BioScrip President and CEO Dan Greenleaf says the company is reinvigorated and on track to right itself.

CORE is key to BioScrip reversal

 - 
03/10/2017

DENVER – BioScrip has pushed closer to its goal of having its core home infusion business make up 85% of its overall revenue, said company executives on a recent earnings call.

Short takes: BioScrip, BOC, Mediware, NASP

 - 
02/08/2017

BioScrip has joined Keep My Infusion Care at Home, a coalition formed in response to a change in the payment model for Medicare Part B home infusion drugs. The Denver-based BioScrip is a leading provider of infusion and home care management solutions

In brief: Bid relief becomes official, BioScrip restructures credit

 - 
12/16/2016

WASHINGTON – President Barack Obama on Dec. 13 signed into law the 21st Century Cures Act, which offers some relief to HME providers in rural areas.

BioScrip restructures credit

 - 
12/14/2016

DENVER – BioScrip has announced a plan to increase its liquidity.

Turnaround king?

Daniel Greenleaf rolls up his sleevs
 - 
11/23/2016

Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.

Pages